炎症信号通路在SYK抑制剂耐药AML中发挥作用
Sarah Tausch1,2, Christina Villinger1,2, Gabriela Alexe3,4
1Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Theodor-Stern Kai 7, 60594, Frankfurt am Main, Germany.
Scientific reports
|April 5, 2025
概括
在急性髓性白血病 (AML) 中对SYK抑制剂的耐药性可能会通过葡萄糖皮质类药物克服. 耐药AML细胞对葡萄糖皮质类药物敏感性增加,炎症信号通路发生变化.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 选择性腺氨酸激酶 (SYK) 抑制剂,如恩托斯普莱提尼布,在急性髓性白血病 (AML) 中具有高HOXA9/MEIS1表达的临床活性.
- 药物耐药性是针对性癌症治疗的一个重大挑战,需要确定替代治疗策略.
研究的目的:
- 为了确定SYK抑制剂耐药AML细胞中的新药敏感性.
- 研究 AML.中对 SYK 抑制剂产生抗性的机制.
主要方法:
- 一个化学图书馆的屏幕被用来识别药物敏感性在耐ospletinib的AML细胞.
- 进行了RNA测序,以分析耐药与天真AML细胞中的基因表达变化.
主要成果:
- 耐恩托斯普莱蒂尼布的AML细胞对葡萄糖皮质类药物表现出增加的敏感性.
- 与原始细胞相比,RNA测序揭示了耐药细胞中通过NF-κB途径丰富的炎症反应和TNFα信号传递.
- 用ospletinib治疗的原始AML细胞显示这些炎症途径的降低调节.
结论:
- 炎症信号传导途径与AML中ospletinib耐药性的发展有关.
- 葡萄糖皮质类药物可能是SYK抑制剂耐药AML的患者的治疗选择.
- 准炎症途径可能是克服AML中SYK抑制剂耐药性的策略.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
The Intrinsic Apoptotic Pathway
5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K


